HaemaLogiX opens enrollment for the phase 1 KOALA trial of KMCAR T-cell therapy in relapsed or refractory kappa-restricted multiple...
Read MoreNovo Nordisk has presented new OASIS 4 sub-analyses at ECO2026, showing strong weight loss and mobility improvements from oral...
Read MoreUCB has expanded its strategic alliance with Cancer Research UK and Cancer Research Horizons to accelerate novel oncology candidates....
Read MoreMyomaker Bio, a Loughborough University spin-out, has launched a world-first lab-grown human muscle platform for drug developers. Boehringer Ingelheim...
Read MoreMSK researchers have reported encouraging long-term follow-up results from a small phase 1 trial of a personalised mRNA vaccine...
Read MoreTransgene has completed patient randomisation in the phase 2 part of its phase 1/2 TG4050 trial in head and...
Read More